Scarica l'app Stockscreener
1.31
0.76%
-0.01
Dopo l'orario di chiusura:
1.32
0.01
+0.76%
Precedente Chiudi:
$1.32
Aprire:
$1.35
Volume 24 ore:
25,190
Relative Volume:
0.58
Capitalizzazione di mercato:
$4.78M
Reddito:
$3,000
Utile/perdita netta:
$-5.16M
Rapporto P/E:
-0.9269
EPS:
-1.4133
Flusso di cassa netto:
$-5.43M
1 W Prestazione:
-13.25%
1M Prestazione:
-30.69%
6M Prestazione:
-73.10%
1 anno Prestazione:
-78.38%
Intervallo 1D:
$1.28
$1.3899
Intervallo di 1 settimana:
$1.20
$1.47
Portata 52W:
$1.20
$9.37
Pulmatrix Inc Stock (PULM) Company Profile
Nome
Pulmatrix Inc
Settore
Industria
Telefono
(888) 355-4440
Indirizzo
945 CONCORD STREET, FRAMINGHAM, MA
Compare PULM vs VRTX, REGN, ARGX, ALNY, INSM
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
PULM
Pulmatrix Inc
|
1.31 | 4.78M | 3,000 | -5.16M | -5.43M | -1.4133 |
VRTX
Vertex Pharmaceuticals Inc
|
438.71 | 111.45B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
761.85 | 80.54B | 14.34B | 4.50B | 3.77B | 41.56 |
ARGX
Argen X Se Adr
|
746.42 | 46.32B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
318.85 | 42.29B | 3.71B | 313.75M | 465.38M | 2.2571 |
INSM
Insmed Inc
|
162.43 | 35.01B | 606.42M | -1.28B | -997.58M | -6.403 |
Pulmatrix Inc Stock (PULM) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2018-02-09 | Iniziato | H.C. Wainwright | Buy |
Pulmatrix Inc Borsa (PULM) Ultime notizie
If You Invested $1,000 in Pulmatrix (PULM) - Stock Titan
FOMO Trade: Will Pulmatrix Inc benefit from current market trendsQuarterly Trade Review & Consistent Income Trade Recommendations - baoquankhu1.vn
FRA:2PU PB Ratio: 1.34 — 15% Above Median - GuruFocus
Pulmatrix and Eos SENOLYTIX Announce $19 Million Merger to Advance Mitochondrial Therapies - Global Legal Chronicle
Pulmatrix shares dive as privately-held pharma company chooses to merge with Gyre Therapeutics instead - MSN
Ideas Watch: Is Pulmatrix Inc in a consolidation phaseQuarterly Trade Summary & Low Risk Investment Opportunities - baoquankhu1.vn
Pulmatrix and Eos SENOLYTIX Announce $19M Merger to Advance AI-Driven Mitochondrial Therapies for Sarcopenia and Aging-Related Diseases 1 - Minichart
Pulmatrix to Merge With Eos SENOLYTIX, Rebrand on Nasdaq - TipRanks
Pulmatrix to Merge With Eos SENOLYTIX; Raises $1M Preferred, Eos Secures Up to $18M - TradingView
Pulmatrix (PULM) plans reverse merger with Eos SENOLYTIX, legacy holders keep ~6% - Stock Titan
Haynes Boone Advises on Pulmatrix–Eos Merger and $19MM Financing - ABF Journal
Pulmatrix to acquire Eos SENOLYTIX in $19M anti-aging deal - Investing.com India
Pulmatrix and Eos SENOLYTIX Unite to Pioneer Anti-Aging Therapies Targeting Mitochondrial Health - Beijing Times
Deal Watch: Pulmatrix Finds New Merger Partner In Eos Senolytix - Citeline News & Insights
Eos SENOLYTIX, Inc. agreed to acquire Pulmatrix, Inc. in a reverse merger transaction. - MarketScreener
Aug Fed Impact: Is Pulmatrix Inc forming higher highs and higher lows2026 Market Mood & Weekly Consistent Profit Watchlists - baoquankhu1.vn
Pulmatrix: Merger With Eos SENOLYTIX To Advance Mitochondrial Therapies - pulse2.com
Pulmatrix To Merge with Eos SENOLYTIX - citybiz
Pulmatrix (PULM) to Acquire Eos Senolytix in Strategic Merger - GuruFocus
Pulmatrix and Eos SENOLYTIX Announce Merger Agreement to Advance Novel Mitochondrial Therapies to Improve Healthspan - PR Newswire
Pulmatrix, Inc. announced that it expects to receive $1 million in funding - marketscreener.com
Buyout Rumor: Can Pulmatrix Inc grow without dilution2026 Closing Moves & Free Technical Confirmation Trade Alerts - baoquankhu1.vn
Pulmatrix (NASDAQ:PULM) Stock Crosses Above Fifty Day Moving Average – Here’s Why - Defense World
Aug Catalysts: What are the analyst revisions for Vroom IncIs Pulmatrix Inc stock a good investment in YEARTrade Exit Report & Expert Verified Stock Movement Alerts - baoquankhu1.vn
Risk Off: What is the earnings history of Pulmatrix IncWeekly Stock Report & Weekly High Conviction Ideas - baoquankhu1.vn
Why Pulmatrix Inc. stock is a value investor pickJuly 2025 Price Swings & Daily Growth Stock Investment Tips - Naître et grandir
Surprises Report: Will Pulmatrix Inc benefit from rising consumer demandShare Buyback & Capital Efficient Trade Techniques - baoquankhu1.vn
Pulmatrix, Inc. (PULM) Competitors - Meyka
PULM Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Pulmatrix Pursues New Reverse Merger After Cullgen Termination - The Globe and Mail
Pulmatrix merger with Cullgen terminated by Chinese firm - Investing.com
Behavioral Patterns of PULM and Institutional Flows - Stock Traders Daily
Pulmatrix Shares Dive As Privately-Held Pharma Company Chooses To Merge With Gyre Therapeutics Instead - Asianet Newsable
Pulmatrix and Cullgen Terminate Merger Agreement - Contract Pharma
Pulmatrix (PULM) Pursues New Merger Opportunities Post Agreement Termination - GuruFocus
Pulmatrix announces termination of prior planned merger and continues pursuit of alternative merger opportunities - marketscreener.com
Pulmatrix Announces Termination Of Prior Planned Merger And Continues Pursuit Of Alternative Merger Opportunities - TradingView
Pulmatrix-Cullgen Merger Agreement Terminated; No Fees Payable - TradingView
CSRC delays leave Pulmatrix merger dead, company hunts new deal - Stock Titan
Pulmatrix, Inc. SEC 10-K Report - TradingView
Pulmatrix, Inc. Reports Earnings Results for the Full Year Ended December 31, 2025 - marketscreener.com
PULM: Revenue fell to nil in 2025 as the company pivots to merger and asset monetization strategies - TradingView
Pulmatrix (NASDAQ: PULM) cuts 2025 loss to $5.2M as Cullgen merger awaits approvals - Stock Titan
Pulmatrix Announces Year-End and Fourth Quarter 2025 Financial Results - PR Newswire
Pulmatrix | 10-K: FY2025 Annual Report - Moomoo
Pulmatrix Announces Year-End and Fourth Quarter 2025 Financial Results | PULM Stock News - Longbridge
PULM PE Ratio & Valuation, Is PULM Overvalued - Intellectia AI
Why Pulmatrix Inc. stock is in analyst buy zone2025 Market Trends & Low Risk Entry Point Guides - mfd.ru
Update Report: Will Pulmatrix Inc benefit from seasonalityVolume Spike & Technical Buy Zone Confirmations - baoquankhu1.vn
(PULM) Movement Within Algorithmic Entry Frameworks - Stock Traders Daily
Earnings Report: What is the earnings history of Pulmatrix IncPortfolio Value Summary & AI Driven Price Forecasts - baoquankhu1.vn
Pulmatrix Inc Azioni (PULM) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.49%
1.47%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):